Intensity Therapeutics Analyst Ratings
Intensity Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $2.77, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 333.21% | Benchmark | → $12 | Reiterates | Speculative Buy → Speculative Buy |
| 08/24/2023 | 333.21% | Benchmark | → $12 | Reiterates | Speculative Buy → Speculative Buy |
| 07/18/2023 | 333.21% | Benchmark | → $12 | Initiates Coverage On | → Speculative Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/14/2023 | 333.21% | 基準 | → 12 美元 | 重申 | 投機性買入 → 投機性買入 |
| 08/24/2023 | 333.21% | 基準 | → 12 美元 | 重申 | 投機性買入 → 投機性買入 |
| 07/18/2023 | 333.21% | 基準 | → 12 美元 | 啓動覆蓋範圍開啓 | → 投機性買入 |
What is the target price for Intensity Therapeutics (INTS)?
Intensity Therapeutics（INTS）的目標價格是多少？
The latest price target for Intensity Therapeutics (NASDAQ: INTS) was reported by Benchmark on November 14, 2023. The analyst firm set a price target for $12.00 expecting INTS to rise to within 12 months (a possible 333.21% upside). 3 analyst firms have reported ratings in the last year.
Benchmark於2023年11月14日公佈了Intensity Therapeutics（納斯達克股票代碼：INTS）的最新目標股價。該分析公司將目標股價定爲12.00美元，預計INTS將在12個月內升至12個月內（可能上漲333.21％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Intensity Therapeutics (INTS)?
分析師對 Intensity Therapeutics (INTS) 的最新評級是多少？
The latest analyst rating for Intensity Therapeutics (NASDAQ: INTS) was provided by Benchmark, and Intensity Therapeutics reiterated their speculative buy rating.
Benchmark對Intensity Therapeutics（納斯達克股票代碼：INTS）的最新分析師評級由Benchmark提供，Intensity Therapeutics重申
When is the next analyst rating going to be posted or updated for Intensity Therapeutics (INTS)?
Intensity Therapeutics（INTS）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Intensity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Intensity Therapeutics was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Intensity Therapeutics的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Intensity Therapeutics的最新評級是在2023年11月14日公佈的，因此您應該預計下一個評級將在2024年11月14日左右公佈。
Is the Analyst Rating Intensity Therapeutics (INTS) correct?
分析師對強度療法 (INTS) 的評級是否正確？
While ratings are subjective and will change, the latest Intensity Therapeutics (INTS) rating was a reiterated with a price target of $0.00 to $12.00. The current price Intensity Therapeutics (INTS) is trading at is $2.77, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的Intensity Therapeutics（INTS）評級，目標股價爲0.00美元至12.00美元。Intensity Therapeutics（INTS）目前的交易價格爲2.77美元，在分析師的預測區間內。